Summary of Classification and Labelling
Notified classification and labelling
General Information
206-120-1 |
11β,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-(dihydrogen phosphate) |
302-25-0 |
Notified classification and labelling according to CLP criteria
Repr. 1B |
H360
(D)
|
H360
(D)
|
|
GHS08 Dgr
|
|
|
|
|
1 |
|
View details
|
Repr. 2 |
H361
|
H361
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Repr. 2 |
H361
|
H361
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
STOT RE 2 |
H373
(Adrenergic and ...)
(oral)
|
H373
|
STOT RE 2 |
H373
(other:Adrenergi...)
(oral)
|
H373
|
Number of Aggregated Notifications: 3